Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma

Qingbin Liu(Jilin Normal University), Shulong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Changlin Ma(Jining First People's Hospital), Xinchen Tian(Jining First People's Hospital), Hengchang Zang(Shandong University), Jiaqi Zhang(Shanghai University of Traditional Chinese Medicine), Fen Liu(Shandong University of Traditional Chinese Medicine), Xiulian Lu, Weiyang Li(Jining Medical University), Yong Yu(Max Delbrück Center), Chenqiao Liu(Jining First People's Hospital), Jingjing Qi(Shanghai Jiao Tong University)
Research Square
July 20, 2023
10.21203/rs.3.rs-3164252/v1
Cited by 1

Related Papers

Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer
|Nature Communications|2022|902
Virus-induced senescence is a driver and therapeutic target in COVID-19
|Nature|2021|344
Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
|Theranostics|2019|71
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC
|Hepatology|2024|60
(-)-Epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury
|Redox Biology|2019|59